Literature DB >> 30316443

Development of a clinical prediction model for diagnosing adenomyosis.

Tina Tellum1, Staale Nygaard2, Else K Skovholt3, Erik Qvigstad4, Marit Lieng4.   

Abstract

OBJECTIVE: To develop a multivariate prediction model for diagnosing adenomyosis using predictors available through transvaginal ultrasonography and clinical examinations.
DESIGN: Prospective observational single-center study.
SETTING: Teaching university hospital. PATIENT(S): One hundred consecutively enrolled premenopausal women aged 30-50 years, undergoing hysterectomy due to a benign condition and not using hormonal treatment. INTERVENTION(S): Preoperative 2-D and 3-D transvaginal ultrasonography investigations were performed, and the results were documented in a standardized form. Clinical information was collected using a questionnaire. Histopathology confirmed the outcome. MAIN OUTCOME MEASURE(S): Diagnostic performance (sensitivity, specificity, area under the curve (AUC)) of a multivariate prediction model for adenomyosis. Independent diagnostic performance of single predictors and their quantitative effect (β) in the final model. RESULT(S): The final model showed a good test quality (area under the curve [AUC] = 0.86, [95% confidence interval = 0.79-0.94], optimal cutoff 0.56, sensitivity of 85%, specificity 78%). The following nine predictors were included ([sensitivity, specificity, β] or [AUC, β]): presence of myometrial cysts (51%, 86%, β = 0.86), fan-shaped echo (36%, 92%, β = 0.54), hyperechoic islets (51%, 78%, β = 0.62), globular uterus (61%, 83%, β = 0.2), normal uterine shape (83%, 61%, β = -0.75), thickest/thinnest ratio for uterine wall (0.61, β = 0.26), maximum width of the junctional zone in sagittal plane (0.71, β = 0.1), regular appearance of junctional zone (31%, 92%, β = -1.0), and grade of dysmenorrhea measured on a verbal numerical rating scale (0.61, β = 0.08). CONCLUSION(S): We have presented a multivariate model for diagnosing adenomyosis that weights predictors based on their diagnostic significance. The reported findings could aid clinicians who are interpreting the heterogeneous appearance of adenomyosis in ultrasonography. CLINICAL TRIAL REGISTRATION NUMBER: NCT02201719.
Copyright © 2018 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  3-D ultrasound; Junctional zone; adenomyosis; prediction model

Mesh:

Year:  2018        PMID: 30316443     DOI: 10.1016/j.fertnstert.2018.06.009

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  7 in total

1.  Higher Risk of Anxiety and Depression in Women with Adenomyosis as Compared with Those with Uterine Leiomyoma.

Authors:  Ni Li; Ming Yuan; Qiuju Li; Miaomiao Ji; Xue Jiao; Guoyun Wang
Journal:  J Clin Med       Date:  2022-05-07       Impact factor: 4.964

2.  A clinical scoring system for the diagnosis of adenomyosis.

Authors:  Muhammet Yıldırır; Hakan Aytan; Hüseyin Durukan; İclal Gürses
Journal:  Turk J Obstet Gynecol       Date:  2022-06-27

Review 3.  Recent advances in understanding and managing adenomyosis.

Authors:  Silvia Vannuccini; Felice Petraglia
Journal:  F1000Res       Date:  2019-03-13

Review 4.  Classifying Adenomyosis: Progress and Challenges.

Authors:  Marwan Habiba; Giuseppe Benagiano
Journal:  Int J Environ Res Public Health       Date:  2021-11-25       Impact factor: 3.390

5.  External validation of the BEST-J score and a new risk prediction model for ESD delayed bleeding in patients with early gastric cancer.

Authors:  Jiaxu Wang; Shanshan Wu; Jie Xing; Peng Li; Shutian Zhang; Xiujing Sun
Journal:  BMC Gastroenterol       Date:  2022-04-20       Impact factor: 2.847

6.  Consensus on revised definitions of Morphological Uterus Sonographic Assessment (MUSA) features of adenomyosis: results of modified Delphi procedure.

Authors:  M J Harmsen; T Van den Bosch; R A de Leeuw; M Dueholm; C Exacoustos; L Valentin; W J K Hehenkamp; F Groenman; C De Bruyn; C Rasmussen; L Lazzeri; L Jokubkiene; D Jurkovic; J Naftalin; T Tellum; T Bourne; D Timmerman; J A F Huirne
Journal:  Ultrasound Obstet Gynecol       Date:  2022-07       Impact factor: 8.678

7.  Evaluation of adenomyosis after gonadotrophin-releasing hormone agonist therapy using ultrasound post-processing imaging: a pilot study.

Authors:  Szu-Yuan Chou; Cindy Chan; Yu-Chieh Lee; Tzu-Ning Yu; Chii-Ruey Tzeng; Chi-Huang Chen
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.